Pfizer

[Guest]

Pfizer (+0.75%) is putting its consumer healthcare business on the trading block, either as a sale or spin-off. 

The drugmaker’s $3.4 billion unit features a medicine cabinet of popular productsyou’ll probably use at least once today, such as ChapStick, Centrum, and Advil. So what’s got Pfizer thinking about drug deals? 

Well, the $10 billion+ from a sale would give it ammo for a blockbuster acquisition(rumor on the street…it’s eyeing BMS). Plus, Pfizer is looking to zero in on its lucrative prescription drug business that has helped boost shares 7.5% YoY. 

This might be déjà vu all over again for Pfizer. It sold its consumer healthcare business to J&J back in 2006 for $16.6 billion only to buy another portfolio (which included Advil and ChapStick) when it acquired Wyeth in 2009. 

So why not write a script for one more?

https://www.morningbrew.com/stories/doctors-orders/

[Just another man]

 

[Mic Drop]

Turns out he meant: Reduce the number of people, [who can't afford our medicine] by 50%

here is the full video

 

 

[Mic Drop]

 

 

[Mic Drop]